Charles Evan Ballantyne
CIK 1371742 · View on SEC EDGAR ↗
First SEC filing: April 12, 2023 · Latest: April 12, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 25, 2015 | AGEN | P | 10,000 | $5.05 | $50,500 | 10,000 Direct | — | Acquired | -92.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 10, 2023 | GANX | Restricted Stock Units | Common Stock (50,000) | — | — | 50,000 | Acquired |
| April 10, 2023 | GANX | Employee Stock Option (right to buy) | Common Stock (100,000) | $4.79 | April 10, 2033 | 100,000 | Acquired |
| June 14, 2016 | AGEN | Stock Option, right to buy | Common Stock (75,000) | $4.16 | March 31, 2026 | 75,000 | Acquired |
| June 14, 2016 | AGEN | Restricted Stock Unit | Common Stock | — | March 31, 2019 | 14,000 | Acquired |
| June 17, 2015 | AGEN | Stock Option, right to buy | Commmon Stock (150,000) | $9.78 | June 17, 2025 | 150,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $235,981 | — | — | — | — | — | — | $483,876 |
| 2015 | $179,038 | $86,100 | — | — | — | — | — | $1,425,944 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.